Clozapine Myocarditis: Symptoms, Fever, Heart Rate, and Monitoring

Clozapine-associated myocarditis develops early in treatment. In an analysis of 75 cases, onset ran from day 10 to day 33, and 83% of cases developed between days 14 and 21.¹ The symptoms are non-specific: flu-like symptoms, fever, fatigue, chest pain and shortness of breath.²

A meta-analysis of 28 studies covering 258,961 people exposed to clozapine found a myocarditis rate of 0.7% and an absolute death rate of 0.04%.³ Fever, chest pain, shortness of breath or a racing heart in the first weeks means contacting the prescriber that day or going to urgent care. The treating clinician decides whether clozapine is held.

Symptoms that need same-day evaluation

The label tells clinicians to consider myocarditis when any of these occur:⁴

• Chest pain
• A fast heart rate or palpitations
• Shortness of breath
• Fever or flu-like symptoms
• Low blood pressure
• ECG changes

The label says myocarditis and pericarditis most frequently present within the first 2 months of treatment.⁴ In a series of 38 cases, nearly all surviving patients had persistent tachycardia and an elevated troponin level.⁵

In a UK audit of clozapine initiation with complete data for 180 patients, tachycardia occurred in more than 40% of patients.⁶ A persistently fast rate is still reported to the prescriber, who decides on testing. The missed doses page covers what the label says about stopping clozapine, and that decision is made with the prescriber.

How common it is depends on where it was measured

Sources: ^{3, 7, 8, 9, 10}

The estimates differ widely between countries. The meta-analysis found higher rates in Australia and noted that observation bias may partly explain them. Its authors concluded that the risk is low and shouldn't be a barrier to a monitored clozapine trial.³ Ronaldson and colleagues argued that the incidence is likely around 3%.¹¹

What monitoring looks like in the first four weeks

Sources: ^{1, 2} These are published schedules. The treating team decides on testing and on stopping.

In the 2011 analysis, 90% of cases had troponin at least twice the upper limit of normal. The protocol encourages continuing clozapine through mild illness.¹ The 2026 consensus drew on 93 clinicians and academics from six continents, and 82.5% of experts endorsed its algorithm. It noted that a threshold of twice the upper limit could produce false-positive troponin results, and that troponin can stay normal in mild or early myocarditis.²

Risk factors: titration speed and valproate

In a case-control study of 105 cases and 296 controls, each additional 250 mg of clozapine given in the first nine days was associated with a 26% higher risk of myocarditis. Concomitant sodium valproate was associated with more than double the risk (odds ratio 2.59), and each decade of age with a 31% increase.¹²

A 2022 meta-analysis also found higher odds with valproate, with a pooled odds ratio of 3.58, and described the results for age and clozapine dose as conflicting.¹³ Thirty-three cases in the case-control study received less than 920 mg in the first nine days, took no valproate and were under 40, and the authors recommended monitoring all patients to day 28.¹²

How fast clozapine is titrated

The 2026 consensus recommended titration slower than the schedules in the Summary of Product Characteristics for clozapine to minimize risk. It set the starting dose at 12.5 mg per day, and the preferred doses were 50 mg at day 7 (chosen by 64.5% of experts) and 100 to 125 mg at day 14 (67.2%).² These are figures prescribers work from, and the prescriber sets the schedule.

Is early fever on clozapine benign?

In a Korean cohort of 1,408 inpatients, 22.1% developed a fever at an average of 15.74 days after starting.⁹

The label describes this fever as generally benign and self-limited, with a peak incidence in the first 3 weeks, while stating that it may necessitate discontinuing treatment.⁴ A 2019 review of 73 articles likewise found fever during initiation most frequently benign and transient, and advised close monitoring because it may be the first stage of a life-threatening reaction.¹⁴

Ronaldson and colleagues read the same fevers differently. They reported that very few fever cases were investigated for myocarditis and argued that the timing of the fever is consistent with a prodrome of undiagnosed myocarditis.¹¹ de Leon describes fever without infection as a mild form of clozapine-induced inflammation during rapid titration, a category that includes myocarditis.¹⁵

Regardless of which reading is correct, a fever in the first weeks calls for same-day contact with the prescriber, who decides on testing and on whether clozapine continues. Constipation, weight gain, seizures and blood counts are on the clozapine side effects page.

Limitations of the evidence

This evidence has limitations. First, the monitoring protocol was derived from an analysis of 75 cases and 94 controls, and its sensitivity for asymptomatic myocarditis is unknown.¹ Second, the titration and valproate findings are observational, and in one case series CRP had been low on the previous weekly test in 5 of 7 patients who developed fever.¹⁶ Nevertheless, the first 4 weeks of titration are described as the highest risk period, and new fever, chest pain, breathlessness or a persistently fast heart rate in that window warrants same-day contact with the prescriber or urgent care.¹⁰

In a crisis: call or text 988, or go to the nearest emergency department. A first episode of psychosis belongs in a hospital-based or coordinated specialty care program.

I start and manage clozapine in an outpatient practice in Chelsea, Manhattan. Details are on the schizophrenia care in NYC page. Clozapine should not be stopped, skipped, or restarted without the prescriber. This page is general information and does not replace an evaluation.

Related: Schizophrenia and psychosis treatment guide · When to start clozapine · Clozapine blood tests after the REMS ended · Clozapine side effects · Missed clozapine doses · Clozapine and suicide risk · Cannabis and psychosis · Schizoaffective vs schizophrenia · Cobenfy vs clozapine · Postpartum psychosis · Injections vs pills · Stimulants and psychosis · Drug-induced psychosis · Clozapine levels · CBT for psychosis · Cannabis after psychosis · Clozapine constipation · Work and school · Clozapine drooling · Early signs in teens · Clozapine weight gain · Genetic and family risk · Who can prescribe clozapine · Schizophrenia and violence · Clozapine in teenagers · Sleepiness, bedwetting, heart rate · When clozapine isn't enough · Clozapine interactions · Benign ethnic neutropenia · Clozapine off-label uses · Starting clozapine · Clozapine and pneumonia · Clozapine seizures · Clozapine in pregnancy · Clozapine rechallenge · Relative refuses treatment · Late-onset schizophrenia · Negative symptoms · First-episode psychosis · Tardive dyskinesia · Stopping antipsychotics · Schizophrenia life expectancy · Key clozapine studies